Navigation Links
Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program
Date:7/9/2008

trials in solid tumor indications, including a Phase III clinical trial in combination with gemcitabine in locally advanced and metastatic pancreatic cancer. Lorus has reported that the overall survival data in this Phase III study did not reach statistical significance, although exploratory analysis yielded promising results in specific patient populations including in patients with ECOG performance status of 0 or 1.

In April 2008, Lorus' subsidiary GeneSense Technologies entered into an exclusive multinational license agreement for Virulizin(R) with Zor Pharmaceuticals LLC to further develop and commercialize Virulizin(R) for advanced pancreatic cancer and other therapy areas in North and South America, Europe, and Israel.

Virulizin(R) study leads to new drug candidate IL-17E

The article entitled "Virulizin(R) induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors" was published online in the journal Cancer Immunology Immunotherapy and is available through PubMed (http://www.ncbi.nlm.nih.gov/PubMed/).

The study showed that Virulizin(R) treatment stimulates the immune system to produce the cytokine IL-17E, which in turn triggers an anticancer effect through activation and tumor recruitment of eosinophils. This novel aspect of the anticancer mechanism of action for Virulizin(R) adds to previous studies showing that Virulizin(R) activates other cells of the immune system, including macrophages and Natural Killer (NK) cells.

A key finding of this report was that IL-17E itself had significant anticancer activity when used in mouse models of human cancers. Preliminary studies have revealed that IL-17E has potent activity against several human tumor types, including colon cancer, melanoma, and pancreatic cancer, with low toxicity. Lorus has patent applications pending in major markets, including Canada, Europe and the United St
'/>"/>

SOURCE Lorus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
4. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
5. Lorus initiates development program exploring novel route of administration for LOR-2040
6. Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
7. Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
10. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
11. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Sequenom, Inc. (Nasdaq: SQNM ), ... and Mr. David Pendarvis to its board of ... ,, Kenneth F. Buechler, Ph.D., was president, chief ... 1988 to 1994, Dr. Buechler was Biosite,s director ... was a senior research scientist for the diagnostics ...
(Date:12/16/2009)... supplement? InVitria has what scientists have been asking for! Zap-CHO ... the growth and productivity of CHO cells. Developed for scientists ... free, well defined and consistent recombinant CHO supplement. , ... ... 2009 -- Scientists working with CHO cells can now access ...
(Date:12/16/2009)... HSP A has been found to be effectinve in improving ... ... 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the ... previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high quality ... yields. HSP-A has been found to be especially effective in ...
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader in the ... of the cutting-edge science behind its lead oncology ... world rediscovered the Cyclin G1 gene ... and disease progression, and thus a prime target ... National Cancer Institute investigating the role of microRNAs ...
Breaking Biology Technology:Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... PROVENT(R) Sleep Apnea Therapy in Limited US MarketsBELMONT, ... privately-held, medical device company, focused on transforming the ... of John McCutcheon as President and Chief Executive ... announced that current CEO Jeffrey Nugent will become ...
... Sinobiopharma Pharmaceutical Group (OTC Bulletin Board: SNBP) is ... Tan as Director of Marketing.Ms. Tan joins Sinobiopharma ... as a China-based Unit Marketing Director for Organon, ... Organon, Ms. Tan held senior marketing management roles ...
... 8 Biopharmaceutical company Kiadis,Pharma reported preliminary ... mismatched bone marrow transplantations. Data was presented ... Roy during the prestigious,Presidential Symposium at the ... Goteborg, Sweden, on Monday, March 30, 2009. ...
Other Biology Technology:Ventus Medical Appoints John McCutcheon as President and CEO 2Sinobiopharma, Inc. Appoints New Director of Marketing 2Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations 2
(Date:12/16/2009)... HARBOR, Fla., Dec. 2 Communication ... a leading supplier of electronic signature solutions ... industry* and the recognized leader** in biometric ... a leading International Electronic Document Management (EDM) ... entered an agreement to provide their products ...
(Date:12/16/2009)... Dec. 9 CSC (NYSE: ... American Association for Laboratory Accreditation awarded the ... 17025:2005 accreditation to the company,s Test Lab, ... Labs located in Fairmont, W.Va. The Test ... in the world to achieve this accomplishment. ...
(Date:12/15/2009)... the British Society for Research on Ageing (BSRA) to ... for an initial period of three years. ... Biogerontology editorial board and will acquire articles for ... society and provide society members with free electronic access ... Biogerontology offers a platform for research which ...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2US Brachytherapy Market to Reach 241 6 Billion by 2015 According to New Report by Global Industry Analysts Inc 49562 1US Brachytherapy Market to Reach 241 6 Billion by 2015 According to New Report by Global Industry Analysts Inc 49562 2US Brachytherapy Market to Reach 241 6 Billion by 2015 According to New Report by Global Industry Analysts Inc 49562 3Harmful Bacteria May Hide on Soft Surfaces in Your Home 49559 1Harmful Bacteria May Hide on Soft Surfaces in Your Home 49559 2Drinking milk in the morning may help stave off lunchtime hunger 8943 1Drinking milk in the morning may help stave off lunchtime hunger 8943 2
... July 2, 2008 Standing in a greenhouse at the ... it appeared that something had gone terribly wrong. Almost ... February in hundreds of small pots were dead. , The ... the pots had been sitting in increasingly saltier water for ...
... -- A Florida State University faculty member who ... of cancer-killing drugs is attracting worldwide attention from ... professor of chemical and biomedical engineering at the ... is using high-powered computers to determine how substances ...
... Ohio -- When chemists want to produce a lot of ... they often turn to catalysts, molecules that speed chemical reactions. ... just the right shape to connect with certain molecules can ... body that help us digest food, get around this problem ...
Other Biology News:Search for salt tolerant grasses aims to improve roadside plantings 2FSU researcher using computers to hone cancer-fighting strategies 2Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3
... Fixed Angle Rotor for use ... Centra CL3CL3R, and Centra-MP4/MP4R. ... sputum samples and other difficult ... individual aerosol containment. Complete with ...
... The MBS Satellite Thermal Cycler ... flexible solution for medium to ... MBS combines the latest in ... software and PC control, resulting ...
... Block MBS Start up kit. Includes configured ... choice of 2 MultiBlock satellite thermal ... blocks. User friendly software. Store/track ... height heated lid. Outstanding uniformity. ...
... VARIOMAG Magnetic Stirrers operate without any moving ... bearings, making VARIOMAG Magnetic Stirrers 100% wear-free ... drive can be hermetically sealed, making it ... is why VARIOMAG Magnetic Stirrers are particularly ...
Biology Products: